Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin.
Am J Clin Oncol. 2000 Dec;23(6):593-8. doi: 10.1097/00000421-200012000-00013.
Am J Clin Oncol. 2000.
PMID: 11202804
Clinical Trial.